News
SSKN
3.050
+3.74%
0.110
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q2 2023
Strata Skin Sciences reported results for the second quarter of 2023. The company reported earnings per share of -90 cents and revenue of $8.25 million. This was below the analyst estimate of -50 cents for the same period. Strata skin Sciences is a maker of skin care products.
Investorplace · 2d ago
Weekly Report: what happened at SSKN last week (0603-0607)?
Weekly Report · 2d ago
STRATA SKIN SCIENCES’ THERACLEAR®X ACNE THERAPY SYSTEM FOUND TO BE SAFE AND EFFECTIVE FOR ACNE LESIONS ACROSS ALL FITZPATRICK SKIN TYPES WITH FAVORABLE TOLERABILITY AND PATIENT SATISFACTION AS PUBLISHED IN PEER REVIEWED JOURNAL
Reuters · 5d ago
Weekly Report: what happened at SSKN last week (0527-0531)?
Weekly Report · 06/03 11:57
Catalyst Watch: Nvidia stock split buzz, COMPUTEX, Walmart's annual meeting, and REITs on display
Seeking Alpha's Catalyst Watch looks at events that may impact stock prices next week. Nvidia stock split buzz, COMPUTEX, Walmart's annual meeting, and REITs on display. The most overbought and oversold stocks in options trading on Robinhood Markets. Macau casino stocks will be on watch after gaming revenue numbers for May are released.
Seeking Alpha · 05/31 19:00
Weekly Report: what happened at SSKN last week (0520-0524)?
Weekly Report · 05/27 12:03
Weekly Report: what happened at SSKN last week (0513-0517)?
Weekly Report · 05/20 11:54
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by to $ during Thursday's pre-market session. SINTX Techs stock increased by $ during the session. Dynatronics (NASdaq:DYNT) and Ontrak stock also moved upwards. Eyenovia shares declined by $ during the same session.
Benzinga · 05/16 12:06
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q1 2024
Strata Skin Sciences reported earnings per share of -10 cents for the first quarter of 2024. The company reported revenue of $ million. This was below the analyst estimate for revenue of $ million. Strata skin Sciences is a company that develops and sells skin care products.
Investorplace · 05/16 00:55
STRATA Skin Sciences Inc reports results for the quarter ended in March - Earnings Summary
STRATA Skin Sciences Inc reports results for the quarter ended in March. The company reported a quarterly adjusted loss of 10 cents per share. Revenue fell to $ million from a year ago; analysts expected a loss of $ million. STRATA skin Sciences Inc shares had risen by this quarter and lost this year.
Reuters · 05/15 21:41
Strata Skin Sciences Releases Q1 2024 Financial Results
TipRanks · 05/15 20:55
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 05/15 20:32
STRATA Skin Sciences GAAP EPS of -$0.10 misses by $0.03, revenue of $6.75M misses by $0.16M
STRATA Skin Sciences, Inc. Q1 GAAP EPS of -$ misses by $ , revenue of $ misses by $. Cash, cash equivalents, and restricted cash at March 31, 2024 were $ million. The company's stock is down 2.7% in the last week.
Seeking Alpha · 05/15 20:28
BRIEF-STRATA Skin Sciences Q1 Net Income USD -3.4 Million
Reuters · 05/15 20:05
STRATA SKIN SCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
Reuters · 05/15 20:05
*Strata Skin Sciences 1Q Loss $3.37M >SSKN
Dow Jones · 05/15 20:05
Press Release: STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
STRATA Skin Sciences reports first quarter 2024 financial results for the quarter ended March 31, 2024. Revenue in the first quarter of 2024 was $ million, down 11% YOY. Gross domestic recurring billings were down 3%. The Company's new strategy is focusing on the treatment of dermatologic conditions.
Dow Jones · 05/15 20:05
Press Release: STRATA Skin Sciences Reports First -2-
XTRAC gross domestic recurring billings represent the amount invoiced to partner clinics when treatment codes are sold to the physician. This excludes international recurring revenues. STRATA Skin Sciences, Inc. Is a medical technology company dedicated to developing, commercializing, and marketing innovative products for dermatologic conditions. This press release includes "forward-looking statements"
Dow Jones · 05/15 20:05
Press Release: STRATA Skin Sciences Reports First -3-
Net loss for the three months ended March 31, 2017 was $3.2 million. The company has a net loss per share of $0.05. The Company's net loss includes the effects of a decrease in the value of its assets and a gain on the sale of assets. The company's cash flows from operating activities were $1.3 million for the quarter.
Dow Jones · 05/15 20:05
*Strata Skin Sciences 1Q Rev $6.75M >SSKN
Dow Jones · 05/15 20:05
More
Webull provides a variety of real-time SSKN stock news. You can receive the latest news about Strata Skin Sciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About SSKN
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.